- Home
- HNNA vs TLPH Comparison
HNNA vs TLPH Comparison
Compare HNNA & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNNA
- TLPH
- Stock Information
- Founded
- HNNA 1989
- TLPH 2005
- Country
- HNNA United States
- TLPH United States
- Employees
- HNNA N/A
- TLPH N/A
- Industry
- HNNA Investment Managers
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- HNNA Finance
- TLPH Health Care
- Exchange
- HNNA Nasdaq
- TLPH Nasdaq
- Market Cap
- HNNA 76.4M
- TLPH 64.7M
- IPO Year
- HNNA N/A
- TLPH 2011
- Fundamental
- Price
- HNNA $9.84
- TLPH $1.30
- Analyst Decision
- HNNA
- TLPH Strong Buy
- Analyst Count
- HNNA 0
- TLPH 1
- Target Price
- HNNA N/A
- TLPH $6.00
- AVG Volume (30 Days)
- HNNA 7.6K
- TLPH 309.0K
- Earning Date
- HNNA 12-10-2025
- TLPH 11-12-2025
- Dividend Yield
- HNNA 5.42%
- TLPH N/A
- EPS Growth
- HNNA 56.56
- TLPH N/A
- EPS
- HNNA 1.25
- TLPH N/A
- Revenue
- HNNA $35,816,000.00
- TLPH $28,000.00
- Revenue This Year
- HNNA N/A
- TLPH N/A
- Revenue Next Year
- HNNA N/A
- TLPH $14,533.26
- P/E Ratio
- HNNA $8.04
- TLPH N/A
- Revenue Growth
- HNNA 32.04
- TLPH N/A
- 52 Week Low
- HNNA $8.43
- TLPH $0.38
- 52 Week High
- HNNA $13.88
- TLPH $1.45
- Technical
- Relative Strength Index (RSI)
- HNNA 51.28
- TLPH 55.89
- Support Level
- HNNA $9.82
- TLPH $1.01
- Resistance Level
- HNNA $10.18
- TLPH $1.35
- Average True Range (ATR)
- HNNA 0.21
- TLPH 0.11
- MACD
- HNNA 0.06
- TLPH -0.01
- Stochastic Oscillator
- HNNA 79.97
- TLPH 73.17
About HNNA Hennessy Advisors Inc.
Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.